Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹1,981.10
Market cap: ₹2,196 Cr
Revenue (annual): ₹384.8 Cr
Net profit (annual): ₹41.48 Cr
P/E (TTM): 48.2×Sector 47.4×
Promoter holding: 59.10%-5.53% QoQ
FII holding: 1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Fund Raise 4 Earnings Call 3 Board Meeting Date 3 Financial Results 2 Board Meeting Outcome 2 Results Correction 1 Regulatory Approval 1 Price Movement Clarification 1 Other Announcement 1 Management Change 1 Capital Structure Change 1 Business Update 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Aug 2026 12:07 IST NSE

Capital Structure Change

Beta Drugs Capital Structure Change

Beta Drugs Limited approved the allotment of 35,383 bonus equity shares. These shares were issued to holders of Compulsorily Convertible Debentures following their conversion.

Read the filing ↗